文献速递眼底病与葡萄膜炎

自动化液体定量在新生血管性年龄相关性黄斑变性抗VEGF治疗中的应用

Application of Automated Quantification of Fluid Volumes to Anti-VEGF Therapy of Neovascular Age-Related Macular Degeneration.
PubMed 文献 · Ophthalmology · 2020-03-16

该研究对HARBOR III期随机试验中1095例新生血管性AMD患者进行事后分析,采用深度学习自动分割并定量视网膜内液、视网膜下液和色素上皮脱离体积。结果显示各液体腔隙有特征性消退模式,液体体积与视功能相关,提示自动化定量可优化治疗管理。

要点

  • 深度学习可自动定量视网膜各腔隙液体体积。
  • 视网膜内液消退最快最明显,色素上皮脱离最慢。
  • 视网膜内液对视力有体积依赖性负向影响。

核心结论

  • 自动化定量液体反应可能改善新生血管性AMD的治疗管理,避免临床医生间的差异,并建立结构与功能的相关性。

研究设计与样本

  • III期随机多中心研究(HARBOR)的事后分析,纳入1095例治疗初治患者。
  • 患者随机接受0.5 mg或2.0 mg雷珠单抗,每月或PRN方案治疗24个月。

主要发现

  • 所有患者所有访视的液体体积均被定量。
  • 视网膜内液消退最快最明显,视网膜下液次之,色素上皮脱离消退最慢。
  • 负荷剂量治疗使所有液体类型接近最低可达水平。
  • 剂量和方案参数与液体体积直接相关。
  • 视网膜内液对视力有体积依赖性负向影响,视网膜下液有弱正向预后效应。

临床怎么用

  • 自动化液体定量可作为监测和指导新生血管性AMD抗VEGF治疗的客观工具。

局限性

  • 原文未报告

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Anti-vascular endothelial growth factor (VEGF) treatment of neovascular age-related macular degeneration (AMD) is a highly effective advance in the retinal armentarium. OCT offering 3-dimensional imaging of the retina is widely used to guide treatment. Although poor outcomes reported from clinical practice are multifactorial, availability of reliable, reproducible, and quantitative evaluation tools to accurately measure the fluid response, that is, a "VEGF meter," may be a better means of monitoring and treating than the current purely qualitative evaluation used in clinical practice. DESIGN: Post hoc analysis of a phase III, randomized, multicenter study. PARTICIPANTS: Study eyes of 1095 treatment-naive subjects receiving pro re nata (PRN) or monthly ranibizumab therapy according to protocol-specified criteria in the HARBOR study. METHODS: A deep learning method for localization and quantification of fluid in all retinal compartments was applied for automated segmentation of fluid with every voxel classified by a convolutional neural network (CNN). Three-dimensional volumes (nanoliters) for intraretinal fluid (IRF), subretinal fluid (SRF), and pigment epithelial detachment (PED) were determined in 24 362 volume scans obtained from 1095 patients treated over 24 months in a phase III clinical trial with randomization to 2 drug dosages (0.5 mg and 2.0 mg ranibizumab) and 2 regimens (monthly and PRN). A multivariable mixed-effects regression model was used to test for differences in fluid between the arms and for fluid/function correlation. MAIN OUTCOME MEASURES: Fluid volume in nanoliters, structure-function as Pearson's correlation coefficient, and as a coefficient of determination (R2). RESULTS: Fluid volumes were quantified in all visits of all patients. Automated segmentation demonstrated characteristic response patterns for each fluid compartment individually: Intraretinal fluid showed the greatest and most rapid resolution, followed by SRF and PED the least. The loading dose treatment achieved resolution of all fluid types close to the lowest levels attainable. Dosage and regimen parameters correlated directly with resulting fluid volumes. Fluid/function correlation showed a volume-dependent negative impact of IRF on vision and weak positive prognostic effect of SRF. CONCLUSIONS: Automated quantification of the fluid response may improve therapeutic management of neovascular AMD, avoid discrepancies between clinicians/investigators, and establish structure/function correlations.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Schmidt-Erfurth U, Vogl WD, Jampol LM, et al. Application of Automated Quantification of Fluid Volumes to Anti-VEGF Therapy of Neovascular Age-Related Macular Degeneration. Ophthalmology. 2020. PMID: 32327254. doi:10.1016/j.ophtha.2020.03.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。